Results

Scholar Rock Holding Corporation

11/30/2021 | Press release | Distributed by Public on 11/30/2021 15:12

Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)